Biomed 2024 Showcases Israel's Resilient Entrepreneurial Spirit
The 22nd Biomed Israel Conference brings together Israeli Biotech startups, senior pharma and healthcare executives, and global investors.
Stay updated with breaking news from Stan Lapidus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The 22nd Biomed Israel Conference brings together Israeli Biotech startups, senior pharma and healthcare executives, and global investors.
SUNNYVALE, Calif. April 6, 2023 (PRWEB) April 06, 2023 -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood
World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board Share Article Drs. Cynthia Ma and Massimo Cristofanilli to Advise on Biomarkers of Response (BoRs) to Drive Better Treatment Outcomes for Patients with Breast Cancer I am impressed by Olaris’s technology and early data suggesting the potential use of a metabolomics signature as an independent and robust predictive biomarker in metastatic breast cancer. - Dr. Cristofanilli WALTHAM, Mass. (PRWEB) ...
Press release content from Business Wire. The AP news staff was not involved in its creation. BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments February 10, 2021 GMT BigHat co-founders Mark DePristo and Peyton Greenside (Photo: Business Wire) SAN CARLOS, Calif.--(BUSINESS WIRE)--Feb 10, 2021-- BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today announced it has raised $19 million in an oversubscribed Series A funding round, led by Andreesse...